Interpreting Quality of Life Data in Advanced Cancer Patients
Author Information
Author(s): Nordin K, Steel J, Hoffman K, Glimelius B
Primary Institution: Uppsala University
Hypothesis
How can quality of life data from clinical trials in advanced gastrointestinal cancer patients be better analyzed and interpreted?
Conclusion
The study found that while some quality of life measures were stable, others varied significantly and could effectively differentiate between treatment groups.
Supporting Evidence
- The mean scores in different subscales did not reflect the outcome of the randomized population due to selective drop-outs.
- The patient-provided summary measure of 'Global health status/QoL' was stable but could not differentiate between treatment groups.
- Three other summary measures showed greater variability and effectively discriminated between the two treatment groups.
Takeaway
This study looked at how to better understand the quality of life for patients with advanced cancer by analyzing their responses to treatment.
Methodology
Data from two randomized trials were reanalyzed to evaluate patient benefit using various quality of life measures.
Potential Biases
The subjective nature of physician evaluations may introduce bias.
Limitations
The study faced issues with selective attrition as many patients dropped out due to death.
Participant Demographics
Patients had pancreatic, biliary, or gastric cancer.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website